Data Submitted to FDA Clarify Interaction Between Addyi and Alcohol By Diana Ernst, RPh Publish Date March 21, 2019
Alzheimer Disease Trials Discontinued Following Disappointing Results With Aducanumab By Diana Ernst, RPh Publish Date March 21, 2019
Does Ranolazine Potentiate the Effects of ACE Inhibitors, Angiotensin Receptor Blockers? By Cassandra Pardini, PharmD Publish Date March 21, 2019
Sunosi Approved for Excessive Daytime Sleepiness With Narcolepsy, OSA By Da Hee Han, PharmD Publish Date March 21, 2019
Zulresso Approved as First Treatment for Postpartum Depression By Da Hee Han, PharmD Publish Date March 20, 2019
FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma By Da Hee Han, PharmD Publish Date March 20, 2019
FDA Warns Company Selling Misbranded Drugs With False Claims By Steve Duffy Digital Content Editor Publish Date March 20, 2019
High Discordance Between LDL-C, Lp(a) Reduction in Response to Evolucumab By Brandon May Publish Date March 20, 2019
Oral Semaglutide NDAs Seeking T2D Indication, CV Risk Reduction By Steve Duffy Digital Content Editor Publish Date March 20, 2019
Levoleucovorin Injection Recalled Due to Presence of Particulate Matter By Steve Duffy Digital Content Editor Publish Date March 19, 2019
Vibegron Cuts Daily Urge Urinary Incontinence Episodes, Micturitions in OAB Study By Da Hee Han, PharmD Publish Date March 19, 2019
Tecentriq Plus Chemotherapy Approved for Initial Treatment of Extensive-Stage Small Cell Lung Cancer By Diana Ernst, RPh Publish Date March 19, 2019
